This announcement is a separate document:
AFT Pharmaceuticals Ltd: AFT updates operating profit guidance to $23m to $25m
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.